The Devotion of Dr. Scott Rocklage in revolutionizing the Healthcare Sector
The achievements of Dr. Scott Rocklage have inspired many people who are planning to or have already ventured in biochemical research or entrepreneurship. Currently, he is the managing partner at 5AM Ventures. He joined the company in 2003 and became a managing partner in the subsequent year.
The Boston-based doctor has been in the health sector for close to three decades and has gained vast experience in healthcare management. This matched up with his key roles in leadership, and great scientific background has established Dr. Rocklage as an effective leader in the pharmaceuticals, healthcare, and venture capital domains.
In addition to his role at 5AM Ventures, he is the chairperson of the boards of Achaogen, Relypsa, and Semprus. Before joining the 5AM Ventures, Dr. Scott was the Chairperson and CEO of Cubist Pharmaceuticals. He also worked at Nycomed Salutar as the President and CEO.
Dr. Scott Rocklage has an impressive education background. He attended the University of California where he pursued a Bachelor’s of Science Degree specializing in Chemistry. He continued his training at the Massachusetts Institute of Technology where he attained a Doctor of Philosophy Degree in Chemistry. While at Massachusetts, he worked closely with Richard R. Schrock, a former Nobel Prize Winner. All his studies were conducted at Schrock’s Lab.
The 61-year old doctor spearheaded the approval of three new drugs applications by the FDA in the United States. The drugs include Omniscan™, Cubicin®, and Teslascan®. Dr. Rocklage has invented and co-invented approximately 30 patents in the States. He is a writer and has more than 100 publications which are subject to peer review.
The main roles of Dr. Rocklage as the managing partner at 5AM Ventures include studying the new aspects of life science, preparing and attending the board meetings, and coordinating with portfolio Company’s Management panel.
The doctor also works with the entrepreneurs such as scientists, physicians, and business executives in the domain of life science. This team works together in shaping ideas into potential drugs to meet previously unattended and emerging needs in the medical sector.
Dr. Rocklage applies his strategic leadership skills to ensure that 5AM Ventures is the company for those firms interested in life sciences. 5AM operates in collaboration with other corporations that invent solutions to solve needs in the healthcare sector.
The company uses superior scientific and medical technology to diagnose, treat, and prevent numerous medical disorders.